Form 4: Twist Bioscience CFO Sells Shares
Insider Transaction (Form 4)
Adam Laponis, Chief Financial Officer of Twist Bioscience Corp, sold 8,057 shares of common stock on October 2, 2026 for $188.88 per share.
Summary
- Open-market sale: disposed of 8,057 Common Stock at $188.88 ($1,521,838) on October 2, 2026; holds 100,576 after (Direct).
Sentiment
Score: 3
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $1,521,838 of stock on the open market.
Insider Transactions
Adam Laponis — Officer (Chief Financial Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-02 | Open-market sale | Common Stock | 8,057 | $189 | $1.5M | 100,576 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-02 | Open-market sale (8,057 shares) |
Keywords
insider transaction, Form 4, TWST, Twist Bioscience Corp, bearish, Adam Laponis
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.